Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.
|This activity is supported by an independent educational grant from Dexcom, Inc.|
Monday, June 27, 2022
11:30am to 1pm ET
The on-demand CE archive of this live webcast is available at:
|Expert Faculty Presenters|
|Dana McCormick, RPh, FAMCP
Director of Pharmacy
Blue Cross Blue Shield of Texas
|Samir Mistry, PharmD, MBA
Vice President of Pharmacy Strategy & Services
Capital Blue Cross
|Monica Peek, MD, MPH
Professor of Medicine
Associate Director, Chicago Center for Diabetes Translational Research
The University of Chicago Medicine
Kelly L. Close
|Who Should Attend|
The primary target audience for this initiative consists of medical directors, registered nurses, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations.
|Statement of Need/Program Overview|
The true impact of diabetes-related severe hypoglycemia (SH) events is often underestimated by payers, with only approximately 5% of self-reported events among pharmacologically treated patients being captured by health care utilization-based surveillance. Continuous glucose monitoring (CGM) represents a significant advancement in the precision management of type 2 diabetes (T2D), providing members from diverse demographics, including minority populations, with the ability to receive a virtually uninterrupted stream of information about the current physiology of their disease. However, many providers cite that prior authorizations may delay treatment and negatively impact clinical outcomes. A smart edit featuring an automated look back in claims data for a previous insulin prescription can be used as the criterion for approval with real-time adjudication, easing the administrative burden for payers and providers and streamlining access for members. This approach serves as a basic blueprint for payers to apply the latest evidence in advancing T2D management with optimal outcomes and cost reduction.
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
Date and Time
Monday, June 27, 2022
11:30am to 1pm ET
|Welcome and Introduction
Dana McCormick, RPh, FAMCP
|The Latest Findings Demonstrating Improved Outcomes and Reduced Resource Utilization with rtCGM in T1 and T2D
Monica Peek, MD, MPH
|Real-Time Continuous Glucose Monitoring Case Scenarios and Follow-up Panel Discussions
Dana McCormick, RPh, FAMCP; Monica Peek, MD, MPH; Samir Mistry, PharmD, MBA; Kelly L. Close
|Audience Q&A Session
|Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
Joint Accreditation Statement
|In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Impact Education, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Physician Continuing Medical Education
Medical Education Resources designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Medical Education Resources designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0003680-9999-22-007-L01-P
Type of Activity: Knowledge
Continuing Nursing Education
Medical Education Resources designates this live activity for a maximum of 1.5 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
No additional fee is required to attend this CME/CPE activity.
If you have any questions, please call (215) 619-8812 or email firstname.lastname@example.org.